Exposing the Cholesterol Myth: Big Pharma and Their Corporate “Mainstream” Media Strike Back

It seems to coincide that when fraudulent medical or nutritional dogma promoted by mainstream medicine or government nutritional institutions starts getting exposed in the alternative media, they both double down with the aid of mainstream media, especially if the result of that exposure is lowered sales of statin drugs and processed non-fat foods. This is what is happening with both statin drugs and saturated fat disinformation. But now the empire is striking back. Cleveland Clinic cardiologist Dr. Steven Nissen writes: "We are losing the battle for the hearts and minds of our patients to websites developed by people with little or no scientific expertise, who often peddle ‘natural’ or ‘drug-free’ remedies for elevated cholesterol levels. This 'Internet-driven cult' denies statins’ benefits and whips up fears of side effects, then profits from the resulting confusion by peddling snake oil. The diversion of patients away from evidence-based therapy by advocates of unproven dietary supplements must be vigorously opposed by physician-scientists. Similarly, the claims that cult diets can reverse heart disease have no scientific basis and represent a danger to public health." Dr. Nissen’s viewpoint was also covered in a MedPage Today article titled “CardioBrief: Statin Denialism Is 'A Deadly Internet-Driven Cult,'" where Dr. James Stein (University of Wisconsin) supported Dr. Nissen’s editorial with more vitriol than even Dr. Nissen expressed, stating: "There is a special place in hell for people who use fear tactics and misinformation to promote books and natural health aids, including crazy diets, at the expense of proven medical therapies, rather than as complimentary options under medical direction. I am not sure why Americans are so susceptible to these charlatans."

Study: Cholesterol-lowering Statin Drugs May Cause Parkinson’s Disease

A Penn State Medical School epidemiological study, reported by Science Daily, is urging physicians to not prescribe statin drugs for Parkinson’s disease symptoms. Evidently, due to earlier studies, cholesterol reducing drugs were considered preventative of Parkinson’s disease. Amazingly, this practice had been going on for some time, thanks to several questionable, and conflicting studies of statin use and Parkinson’s disease. The most recent study was conducted at the Penn State College of Medicine earlier this year (2017.) Their conclusion asserts that statin drugs should not be used as a Parkinson’s disease (PD) preventative. A previous study claimed patients who stopped taking statin drugs were more prone to Parkinson’s disease, thus statin drugs were helpful for preventing Parkinson’s. The Penn State study provided evidence that the opposite is true. Statin drug use can lead to Parkinson’s disease.

Alert: Amount of People Recommended for Cholesterol-lowering Statin Drugs Has Tripled

Shocking news! Two studies were recently published that endorse 2013 guidelines for a wider use of statin drugs. As reported in the Journal of the American Medical Association (JAMA), out of over 2400 people, 39% were statin eligible, compared with 14% by the old 2004 guidelines. In one fell swoop, the amount of people recommended for statin use was tripled! This is not surprising given the amount of revenue from statin drug sales. Who makes the guidelines? Doctors on Big Pharma payroll, that’s who.

The Grave Dangers of Statin Drugs—and the Surprising Benefits of Cholesterol

Heart disease, as many of us know, is one of the leading causes of death in the US, killing about 610,000 people each year. Big Pharma—in the belief that cholesterol is the primary factor in heart disease—developed statin drugs that would lower cholesterol and reduce the risk of heart disease. The drugs, which have been accompanied by massive marketing campaigns, are huge moneymakers for the drug industry, to the tune of about $29 billion worth of sales in 2013. That’s the kind of outrageous money you make when you convince one in four Americans over the age of 45 to take statins.

How Cholesterol-lowering Statin Drugs Can Interfere with Your Heart Health

Cholesterol-lowering statin drugs may stimulate atherosclerosis and heart failure. Statins inhibit the synthesis of vitamin K2 in your body; vitamin K2 protects your arteries from calcification. Statins may also damage your heart by interfering with CoQ10 production, causing mitochondria damage, and interfering with selenium-containing proteins.

Japanese Research Exposes Statin Scam: People with High Cholesterol Live Longer

Four Japanese researchers published an analysis on cholesterol guidelines and statin drugs in the April 2015 edition of the Annals of Nutrition and Metabolism. Dr. Malcolm Kendrick, the Scottish doctor who wrote "The Great Cholesterol Con" recently stated on his blog that he has read the entire 116 page review: "For many years I have told anyone who will listen that, if you have a high cholesterol level, you will live longer. Equally, if you have a low cholesterol level, you will die younger. This, ladies and gentlemen, is a fact. The older you become the more beneficial it is to have a high cholesterol level. This fact has become more difficult to demonstrate recently as so many people have been put on statins that the association between cholesterol levels and mortality has been twisted, bent and pumelled into the weirdest shapes imaginable. However, Japan, provides some very interesting data."

Another Study Shows Strong Link Between Cholesterol-lowering Statin Drugs and Diabetes

Another study has confirmed that statin drug use increases one's chance of developing diabetes. Statin drugs are the all-time leading prescription drugs sold in the U.S. and around the world, prescribed by doctors to lower people's cholesterol levels. It is estimated that one out of every 4 people in the United States over the age of 50 is currently taking statin drugs for cholesterol. This current study just published looked at 26,000 beneficiaries of Tricare, the military health system. They found that those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes. The study was published in the Journal of General Internal Medicine. This just the latest study to link statin drugs to diabetes, especially in women. Studies published in 2014 caused over 2000 lawsuits to be filed against Pfizer, the maker of the best-selling drug of all-time, Lipitor.